| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |